化工社化工社 化学情報印刷レポート · 研究参考用
Salbutamol → Methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Salbutamol | HCID 2083 | — |
| 反応物 | Acetophenone | HCID 7410 | — |
| 反応物 | N-(1,1-Dimethylethyl)benzenemethanamine | HCID 76908 | — |
| 反応物 | Bromoacetyl-2-hydroxybenzoate | HCID 21684415 | — |
| 生成物 | Methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate | HCID 12814682 | — |
反応手順
Albuterol has been prepared, see Irish Patent Specification No. 31391, Aug. 9, 1972, starting from the appropriate acetophenone derivative methyl-5-(bromoacetyl-2-hydroxybenzoate, by condensation with N-(1,1-dimethylethyl)benzenemethanamine in the presence of base to form the ketonic ester, methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate. The ketonic ester is reduced with lithium aluminum hydride in tetrahydrofuran under nitrogen to yield α1 -[[(1,1-dimethylethyl)-(phenylmethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol which is subsequently debenzylated with hydrogen in the presence of palladium on carbon catalyst to produce albuterol.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US05011993 |
| 出典データセット | uspto-grants-1991_04 |
| ORD ID | ord-5b8dcbadf97f4773909981ee451ff8e5 |
| 出典メモ | uspto-grants-1991_04 |